- New alliance will crack down on adulterated products touting dietary supplement claims
- Moving PSE to Rx-only in Mo. lacks fiscal sense
- Pharmacy crime: Pushing back against rising wave
- Walgreens allies with HHS to launch free flu shot outreach to disadvantaged
- Harvard doctor calls for greater supplement regulation in NEJM
SILVER SPRING, Md. — The Food and Drug Administration has appointed a new chief of staff for commissioner Margaret Hamburg, according to a letter sent to agency employees Monday.
In the letter, Hamburg announced the appointment of Lisa Barclay. Barclay, currently a partner at the Washington law firm Zuckerman Spaeder, will replace Molly Muldoon, who was previously chief of staff and more recently the agency's acting COO.
Barclay previously worked with the FDA in the 1990s, with the Commissioner's Office of Policy, and also has worked on Capitol Hill and as a law clerk for senior judge William Bryant of the U.S. District Court for the District of Columbia.